Microbiome, Aging, and the Synthetic Immune System: A New Frontier in Geroscience

How one Texas-based company is creating a universal antimicrobial drug, and trying to tackle aging along the way

Hi! I am Andrii Buvailo, and this is my weekly newsletter, ‘Where Tech Meets Bio,’ where I talk about technologies, breakthroughs, and great companies moving the biopharma industry forward.

If you've received it, then you either subscribed or someone forwarded it to you. If the latter is the case, subscribe by pressing this button: